Currently Viewing:
Supplements The Patient Assistance Safety Net: How Many Need Help? How Many Are Helped?
Rising Out-of-Pocket Costs Threaten an Already Vulnerable Population: An Introduction to the PAN Foundation and AJMC® Collaborative Supplement
Dan Klein, President and CEO, Patient Access Network Foundation
Ensuring Access to Prescription Medications in the Post-ACA Healthcare Access Landscape: The Essential Role of FQHCs in the Safety Net for the Underinsured
Lizheng Shi, PhD, MSPharm, MA; M. Kristina Wharton, MPA, MPH; and Alisha Monnette, MPH
Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending
Todd Yezefski, MD; Jordan Steelquist, BA; Kate Watabayashi, BA; Dan Sherman, MA; and Veena Shankaran, MD
Currently Reading
A Descriptive Study of Patients Receiving Foundational Financial Assistance Through Local Specialty Pharmacies
Julia Zhu, MPH, MS; Randall Odebralski, MBA; Safia Boghani, MPH; Clorinda Walley; Frank Koen, RPh; Chad Conley; and Heather S. Kirkham, PhD, MPH

A Descriptive Study of Patients Receiving Foundational Financial Assistance Through Local Specialty Pharmacies

Julia Zhu, MPH, MS; Randall Odebralski, MBA; Safia Boghani, MPH; Clorinda Walley; Frank Koen, RPh; Chad Conley; and Heather S. Kirkham, PhD, MPH
Local specialty pharmacies collaborated with a charitable assistance organization to provide a safety net and to facilitate care for patients with chronic illnesses, allowing them to focus on receiving and adhering to medication, rather than on financial toxicity.
ABSTRACT

Objectives: To describe the population of patients who received financial assistance from the Good Days Foundation (GDF) as facilitated by Walgreens local specialty pharmacies (LSPs).

Study Design: This was a retrospective descriptive study.

Methods: This study used a joint foundational and pharmacy claim database between January 1, 2014, and December 31, 2016.

Results: Among 1572 eligible patients who received GDF financial assistance as facilitated by Walgreens LSPs, 1524 had disease state information and 14 of these patients receveived financial assistance for 2 disease states (patient count denominator, 1538). The top 3 disease states by patient count were oncology (1403; 91.2%), multiple sclerosis (49; 3.2%), and hepatitis C (39; 2.5%). Of the 777 patients who had complete data and disease state information, 2 received finanical assistance for 2 disease states (denominator, 779); oncology remained the disease with the highest patient count (724; 92.9%). The mean annual financial assistance per patient was highest for hepatitis C ($4156), followed by oncology ($3603) and miscellaneous/rare disease ($1829), which covered 98.8%, 99.3%, and 99.6% of these patients' total co-pay requirements, respectively. In addition to prescription co-pay assistance, 21 patients received travel assistance of $554 per year per patient from GDF. The mean persistence of oncology patients was 170.7 days without a 30-day gap over 1 year of observation time.

Conclusions: The facilitation of treatment by GDF and Walgreens LSPs may be the key to many patients receiving their treatment and maintaining medication persistence. GDF co-pay assistance helped cover most out-of-pocket costs associated with medications and aided with travel expenses for patients, especially in the area of oncology. For many patients, this meant reducing the significant financial barriers to accessing care and facilitating the necessary treatment for their chronic or life-altering disease. Without this assistance, many patients would simply not have been able to meet the expected medication persistence and thus would have received suboptimal treatment.

Am J Manag Care. 2018;24(5 Suppl):S80-S84

Become a Member to see the rest of this article and get access to all of our articles and resources. Membership is Free!

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!